Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effect of Dapagliflozin on Inflammation and Endothelial Function

NCT02608905 is registered in ClinicalTrials.gov with Baylor College of Medicine as lead sponsor.

NCT NCT02608905
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02608905 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effect of Dapagliflozin on Inflammation and Endothelial Function
Lead sponsor
Baylor College of Medicine
Phase
Phase 4
Overall status
Terminated
Start date
November 30, 2015
Completion date
March 31, 2019
Enrollment
17 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

type 2 diabetes mellitus